# Signase

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/signase

- Industry: Biotechnology
- Headquarters: Houston, US
- Latest round: Seed (May 1, 2000)
- Investors on record: 3

## About

Based in US, Signase is a biopharmaceuticals company. It focuses on the development of inhibitors of protein tyrosine kinases.

## Funding rounds

- Seed, May 1, 2000 — Pappas Capital, Tripos, BioCapital

## Investors

- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Seed
- Tripos — Seed
- BioCapital — Seed